Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 582

recruiting
3 983
countries
28
conditions
2 109

10 385 trials match your criteria

Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years

Myasthenia gravis

Not recruiting

Study on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years

Study on the Safety of EDV2209 for Patients with Brain Bleeding (Subarachnoid Hemorrhage)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Study on the Safety and Initial Effects of AAV9-CAG-coh-SGSH in Children with Sanfilippo A Syndrome

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years

Study on Lutetium-177-PSMA and 18F-PSMA-1007 for Patients with Oligo-metastatic Hormone Sensitive Prostate Cancer

Registered drugNo placebo
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years

Study on Gene Therapy with Autologous Stem Cells and Drug Combination for Children with Mucopolysaccharidosis Type I Hurler Variant

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years

Study on Prenatal Treatment of Congenital Cytomegalovirus Infection with Letermovir and Valaciclovir for Pregnant Women with CMV-Infected Fetuses

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Valaciclovir

Study of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab

Study on Zolbetuximab and mFOLFOX6 for Patients with Advanced Gastric or Gastroesophageal Junction Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Zolbetuximab

Follicular lymphoma

Not recruiting

Study Comparing Axicabtagene Ciloleucel with Standard Treatment for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Vincristine Sulfate

Study of Lurbinectedin and Pembrolizumab for Patients with Relapsed Small Cell Lung Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Binge eating

Not recruiting

Study on Hydrocortisone and Food Exposure Therapy for Patients with Binge Eating Disorder

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Hydrocortisone
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.